The E-cadherin-GFP mouse allows in situ quantification of E-cadherin mobility
•
We monitored E-cadherin mobility during tissue homeostasis and disease development
•
Invasive pancreatic cancer driven by mutant Kras/p53 increases E-cadherin mobility
•
Dasatinib treatment reverts E-cadherin mobility and reinforces tumor cell junctions
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.